These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23530389)

  • 1. Coping with a pertussis outbreak in Alamance County, North Carolina.
    Shapley-Quinn K
    N C Med J; 2013; 74(1):68-9. PubMed ID: 23530389
    [No Abstract]   [Full Text] [Related]  

  • 2. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 3. Priming with whole-cell versus acellular pertussis vaccine.
    Liko J; Robison SG; Cieslak PR
    N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
    [No Abstract]   [Full Text] [Related]  

  • 4. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccines for adolescents and adults.
    Cherry JD
    Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
    [No Abstract]   [Full Text] [Related]  

  • 8. What's wrong with acellular pertussis vaccines?
    Wiedermann BL
    Clin Ther; 2013 Feb; 35(2):115-8. PubMed ID: 23375491
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.
    Van Damme P; McIntyre P; Grimprel E; Kuriyakose S; Jacquet JM; Hardt K; Messier M; Van Der Meeren O
    Vaccine; 2011 Aug; 29(35):5932-9. PubMed ID: 21718738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
    Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
    Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of pertussis and use of acellular pertussis vaccines in Japan.
    Kuno-Sakai H; Kimura M
    Dev Biol Stand; 1997; 89():331-2. PubMed ID: 9272368
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number and order of whole cell pertussis vaccines in infancy and disease protection.
    Sheridan SL; Ware RS; Grimwood K; Lambert SB
    JAMA; 2012 Aug; 308(5):454-6. PubMed ID: 22851107
    [No Abstract]   [Full Text] [Related]  

  • 16. TDM Journal Club: Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis Immunization During Pregnancy.
    Leibson T; St-Onge M; Koren G
    Ther Drug Monit; 2015 Jun; 37(3):283-4. PubMed ID: 25271727
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis vaccine controversies and acellular pertussis vaccine.
    Shah RC; Shah AR
    Indian J Pediatr; 2003 Jun; 70(6):485-8. PubMed ID: 12921317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
    Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
    Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease.
    Cherry JD
    N Engl J Med; 2012 Aug; 367(9):785-7. PubMed ID: 22894554
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.